Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Topical Ruxolitinib in Vitiligo: Efficacy, Regional Approvals, and Treatment Strategies in African American Patients
Dr. Latanya Benjamin, MD, FAAD, FAAP, discusses the role of topical ruxolitinib cream in managing vitiligo and its effectiveness in a 25-year-old female patient.
EP: 1.Patient vs Provider Perceptions: Expert Opinions on Addressing the Emotional Impact of Vitiligo
EP: 2.Vitiligo in a 35-Year-Old Female: Case-Based Discussion, Treatment Sequencing, and Practical Insights
EP: 3.Vitiligo Case-Based Discussion: Impact of Stigma, Social Perception, and Practical Management Strategies
Now Viewing
EP: 4.Topical Ruxolitinib in Vitiligo: Efficacy, Regional Approvals, and Treatment Strategies in African American Patients
EP: 5.Vitiligo Care Personalized for Each Patient: Part 2
Recent Videos
Related Content
